Mezym (Pancreas Powder From Porcine)

The porcine pancreas powder in Mezym contains a blend of digestive enzymes—amylase, lipase and proteases—that are released in the small intestine. These enzymes catalyze the breakdown of carbohydrates, fats and proteins into absorbable units, compensating for the patient’s insufficient endogenous pancreatic secretion and reducing malabsorption symptoms.

The appropriate dose of Mezym is individualized and determined by the prescribing healthcare professional based on the patient’s age, weight, severity of enzyme deficiency, and dietary fat content. Patients should follow the prescriber’s instructions and adjust the dose only under medical supervision.

Safety data for Mezym during pregnancy or lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers should evaluate the risk‑benefit profile and discuss alternatives with the patient.

To order Mezym, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Mezym is a porcine‑derived enzyme powder, offering a broad spectrum of amylase, lipase and proteases similar to other pancreatic enzyme replacement therapies. Compared with enteric‑coated capsules, the powder can be mixed with food for flexible dosing, but both formulations aim to achieve comparable digestive support when used as directed.

Store Mezym at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and direct sunlight. Keep the container tightly closed after each use and avoid exposure to high humidity, which could affect enzyme activity.

Mezym is taken orally, typically mixed with a small amount of soft food or liquid immediately before or during a meal. The exact timing and amount should follow the prescribing clinician’s guidance to match the enzyme dose with the fat content of the meal.

Serious risks include allergic reactions such as rash, swelling, or anaphylaxis, and severe abdominal pain that may signal pancreatitis exacerbation. Patients should seek immediate medical attention if they experience difficulty breathing, persistent vomiting, or intense abdominal discomfort.

Mezym should not be used by individuals with a known hypersensitivity to porcine proteins or any of its excipients. Patients with severe gastrointestinal disorders that affect absorption, or those who have had a recent allergic reaction to pancreatic enzyme products, should avoid using Mezym unless directed by a physician.